About Us
Company Profile
Vision Values & Promise
Management
Board of Directors
Executive Leadership Team
Locations Worldwide
Subsidiaries
Group Ombudsperson
Business Segments
Radiopharma
Allergy Immunotherapy
CDMO Sterile Injectables
Generics
Contract Research Development & Manufacturing Organisation
Drug Discovery Service
Active Pharmaceutical Ingredients
Proprietary Novel Drugs
Business Enablers
Manufacturing
R&D and Intellectual Property
Business Excellence
Human Resource
Supply Chain
Investors
Financials
Quarterly Results
Investor Presentation
Annual Reports
Annual Return
Subsidiaries Accounts
Intimation to Stock Exchanges
Investor Meets
Stock Information
Share Price Graph
Historical Share Price
Analyst Coverage
Listing
Sub Division of Shares
Equity History
Investor Information
Change of Name
Scheme of Arrangement
Share Holding Pattern
Share Transfer Information
Distribution Pattern
Dividend Payment
Cost Spilit Letter
FAQs
Forms
Updation of KYC details
Credit Ratings
Corporate Governance
Philosophy
Board Structure
Policies and Codes
Duties of Directors
Postal Ballot
Unclaimed Dividend & Shares
Investor Feedback Form
Investor Contact
Nodal Officer
Institutional Investors
Investor Grievances
Registrar and Transfer Agent
KMP - Reg. 30
Disclosure
Online Dispute Resolution
Sustainability
Overview
Corporate Social Responsibility
Sustainable Development Goals
Safety and Occupational Health
Stakeholder Engagement
Environment
Environmental Compliance
Fly Ash Stock Report
Policies
Climate Change Mitigation and Energy Conservation Policy
Environmental, Health and Safety Policy
Sustainability Policy
Biodiversity Policy
Biomedical Waste Information
Sustainability Report
Sustainability Contact
About Us
Company Profile
Vision Values & Promise
Management
Board of Directors
Shyam S Bhartia
Hari S Bhartia
Sushil Kumar Roongta
Vivek Mehra
Arun Seth
Shirish G. Belapure
Shivpriya Nanda
Harsh Mahajan
Priyavrat Bhartia
Arjun Shanker Bhartia
Arvind Chokhany
Jinang Pratap Parekh
Executive Leadership Team
Locations Worldwide
Subsidiaries
Group Ombudsperson
Business Segments
Radiopharma
Allergy Immunotherapy
CDMO Sterile Injectables
Generics
Contract Research Development & Manufacturing Organisation
Drug Discovery Service
Active Pharmaceutical Ingredients
Proprietary Novel Drugs
Business Enablers
Manufacturing
R&D and Intellectual Property
Business Excellence
Human Resource
Supply Chain
Investors
Financials
Quarterly Results
Investor Presentation
Annual Reports
Annual Return
Subsidiaries Accounts
Intimation to Stock Exchanges
Investor Meets
Stock Information
Share Price Graph
Historical Share Price
Analyst Coverage
Listing
Sub Division of Shares
Equity History
Investor Information
Change of Name
Scheme of Arrangement
Share Holding Pattern
Share Transfer Information
Distribution Pattern
Dividend Payment
Cost Spilit Letter
FAQs
Forms
Updation of KYC details
Credit Ratings
Corporate Governance
Philosophy
Board Structure
Policies and Codes
Policy on Materiality of Related Party Transactions and Dealing with Related Party Transactions
Policy on Board Diversity
Policy for Determining Material Subsidiaries
Whistle Blower Policy
Corporate Social Responsibility Policy
Code of Conduct for Directors and Senior Management
Code for Independent Directors
Appointment and Remuneration Policy
Familiarisation Programme for Independent Directors
Code of Practices and Procedures for Fair Disclosure of Unpublished Price Sensitive Information
Policy for Determination of Materiality of Events and Information
Archival Policy
Dividend Distribution Policy
Silent Period Policy
Corporate Tax Policy
Grievance Redressal policy
Risk Management Policy
Duties of Directors
Independence Criteria for Directors
Postal Ballot
Unclaimed Dividend & Shares
Investor Feedback Form
Investor Contact
Nodal Officer
Institutional Investors
Investor Grievances
Registrar and Transfer Agent
KMP - Reg. 30
Disclosure
Online Dispute Resolution
Sustainability
Overview
Corporate Social Responsibility
Sustainable Development Goals
Safety and Occupational Health
Stakeholder Engagement
Environment
Environmental Compliance
Fly Ash Stock Report
Policies
Climate Change Mitigation and Energy Conservation Policy
Environmental, Health and Safety Policy
Sustainability Policy
Biodiversity Policy
Biomedical Waste Information
Sustainability Report
Sustainability Contact
News
Careers
Global Opportunities
Code of Conduct
Fraud Alert Statement
Fun at Work
Diversity and Inclusion
Campus Hiring
Policies
Downloads
Brochures
Annual Report
Sustainability Report
Contact
Addresses
Enquiry Form
News
Careers
Global Opportunities
Code of Conduct
Fraud Alert Statement
Fun at Work
Diversity and Inclusion
Campus Hiring
Policies
Downloads
Brochures
Annual Report
Sustainability Report
Contact
Addresses
Enquiry Form
What are you looking for?
×
Investors
Home
Investors
Investor Meets
Investor Meets
2023-24
Click to download a PDF below.
Pharmova_Investor, Analyst Meeting – March 12, 2024
2021-22
Click to download a PDF below.
Pharmova_Investor, Analyst Meetings - Aug 31, 2021
Pharmova_Investor, Analyst Meetings - Aug 21, 2021
Pharmova_Investor, Analyst Meetings - Aug 16, 2021
Pharmova_Q1 FY22 Concall Schedule - July 15,2021
Pharmova_Investor, Analyst Meetings - June 23, 2021
Pharmova_Investor, Analyst Meetings - June 10, 2021
Pharmova_Q4 FY21 Concall Schedule - May 28,2021
2020-21
Click to download a PDF below.
JLL_Q3 FY21 Concall Schedule - Jan 29,2021
JLL_Q2 FY21 Concall Schedule - Oct 28,2020
JLL_Q1 FY21 Concall Schedule - Aug 28,2020
JLL_Q4 FY20 Concall Schedule - May 25,2020
2019-20
Click to download a PDF below.
JLL _Q3 FY20 Concall Schedule - Jan 23, 2020
JLL _Q2 FY20 Concall Schedule - Oct 17, 2019
JLL _Q1 FY20 Concall Schedule- July 19, 2019
2018-19
Click to download a PDF below.
JLL_Q4 FY19 Concall Schedule - May 09, 2019
JLL_Investor / Analyst Meetings - Mar 05, 2019
JLL_Investor / Analyst Meetings - Feb 13, 2019
JLL _Q3 FY19 Concall Schedule- Jan 25, 2019
JLL_Investor / Analyst Meetings - Dec 14, 2018
JLL _Q2 FY19 Concall Schedule - Oct 15, 2018
JLL _Q1 FY19 Concall Schedule - July 20, 2018
2017-18
Click to download a PDF below.
JLL_Q4 FY18 Concall Schedule - May 02, 2018
JLL_Q3 FY18 Concall Schedule - Jan 10, 2018
JLL_Q2 FY18 Concall Schedule - Oct 18, 2017
JLL_Investor / Analyst Meetings - Sep 25, 2017
JLL_Investor / Analyst Meetings - Sep 19, 2017
JLL_Investor / Analyst Meetings - Sep 04, 2017
JLL_Investor / Analyst Meetings - Aug 01, 2017
JLL_Q1 FY18 Concall Schedule - July 04, 2017
2016-17
Click to download a PDF below.
JLL_Q4 FY17 Concall Schedule - May 11, 2017
JLL_Investor / Analyst Meetings - Feb 28, 2017
JLL_Q3 FY17 Concall Schedule - Jan 19, 2017
JLL_Investor / Analyst Meetings - Jan 03, 2017
JLL_Investor / Analyst Meetings - Nov 15, 2016
JLL_Q2 FY17 Concall Schedule - Oct 18, 2016
JLL_Investor / Analyst Meetings - Sep 23, 2016
JLL_Q1 FY17 Concall Schedule - July 27, 2016
JLL_Investor / Analyst Meetings - Jun 28, 2016
JLL_Investor / Analyst Meetings - May 09, 2016
JLL_Investor / Analyst Meetings - Apr 20, 2016
JLL_Investor / Analyst Meetings - Apr 11, 2016
2015-16
Click to download a PDF below.
JLL_Q4 FY16 Concall Schedule - May 19, 2016
JLL_Investor / Analyst Meetings - Mar 15, 2016
JLL_Investor / Analyst Meetings - Feb 24, 2016
JLL_Q3 FY16 Concall Schedule - Jan 28, 2016
Investors
Financials
Quarterly Results
Investor Presentation
Annual Reports
Annual Return
Subsidiaries Accounts
Intimation to Stock Exchanges
Investor Meets
Stock Information
Share Price Graph
Historical Share Price
Analyst Coverage
Listing
Sub Division of Shares
Equity History
Investor Information
Change of Name
Scheme of Arrangement
Share Holding Pattern
Share Transfer Information
Distribution Pattern
Dividend Payment
Cost Spilit Letter
FAQs
Forms
Updation of KYC details
Credit Ratings
Corporate Governance
Philosophy
Board Structure
Policies and Codes
Duties of Directors
Postal Ballot
Unclaimed Dividend & Shares
Investor Feedback Form
Investor Contact
Nodal Officer
Institutional Investors
Investor Grievances
Registrar and Transfer Agent
KMP - Reg. 30
Disclosure
Online Dispute Resolution